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Phylogenetic evidence suggests that endemic and epi-
demic dengue viruses (DENV), transmitted among humans
by the anthropophilic mosquitoes Aedes aegypti and Ae.
albopictus, emerged when ancestral, sylvatic DENV trans-
mitted among nonhuman primates by sylvatic Aedes mos-
quitoes adapted to these peridomestic vectors. We tested
this hypothesis by retrospectively examining evidence for
adaptation of epidemic and endemic versus sylvatic strains
of DENV-2 to Ae. albopictus and Ae. aegypti. First and sec-
ond-generation offspring of mosquitoes from different geo-
graphic regions in the Americas and Southeast Asia were
tested for their susceptibility to epidemic/endemic and syl-
vatic DENV-2 isolates from West Africa, Southeast Asia,
and Oceania. Both Aedes species were highly susceptible
(up to 100% infected) to endemic/epidemic DENV-2 strains
after ingesting artificial blood meals but significantly less
susceptible (as low as 0%) to sylvatic DENV-2 strains. Our
findings support the hypothesis that adaptation to perido-
mestic mosquito vectors mediated dengue emergence
from sylvatic progenitor viruses.
D
engue is caused by any of four antigenically distinct
serotypes of dengue virus (DENV), family
Flaviviridae. An estimated 100 million annual dengue
cases occur each year in tropical cities, in which more than
2.5 billion people (almost half of the global population) are
at risk (1). Infection with one DENV serotype confers life-
long protection against homologous reinfection, while a
subsequent heterologous infection increases the likelihood
of a more severe form of the disease (2–4). 
Dengue has four clinical manifestations: 1) undifferen-
tiated illness, 2) classic dengue fever, 3) dengue hemor-
rhagic fever, and 4) dengue shock syndrome. Un-
differentiated dengue, the most common syndrome, occurs
when a DENV infection is asymptomatic or mildly symp-
tomatic. Dengue fever involves an abrupt febrile illness
lasting 2–7 days, accompanied by malaise, headache,
retroorbital pain, myalgia, and arthralgia of such great
intensity that it has earned the lexicon “break-bone” fever
(5,6). Dengue hemorrhagic fever progresses to hemorrhag-
ic manifestations and plasma leakage caused by increased
vascular permeability. Dengue shock syndrome is charac-
terized by circulatory failure and is the most lethal dengue
syndrome (7). 
Within forest habitats of West Africa, Malaysia, and
probably Vietnam, zoonotic, sylvatic dengue cycles have
been described involving Aedes spp. mosquitoes and mon-
keys (8–10). Sylvatic DENV vectors in Africa include
Aedes (Stegomyia) africanus, Ae. (S.) luteocephalus, Ae.
(S.) opok, Ae. (Diceromyia) taylori, and Ae. (D.) furcifer
(10); in Malaysia, Ae. niveus has been implicated in trans-
mission (8,9). These sylvatic cycles, probably involving
only DENV-2 in West Africa but all four serotypes in
Malaysia, are believed to represent the ancestral DENV
cycles from which epidemic/endemic (henceforth referred
to as endemic) strains of DENV-1–4 evolved independent-
ly hundreds to thousands of years ago (11). Although
humans occasionally become infected with sylvatic DENV
in West Africa and perhaps in Asia, they are tangential to
the maintenance cycle, which involves sylvatic Aedes spp.
mosquito vectors and nonhuman primates as reservoir
hosts. In contrast to the sylvatic cycles, epidemic DENV
cycles involving transmission among humans by Ae.
(Stegomyia) aegypti, Ae. (S.) albopictus, and other anthro-
pophilic  Aedes species have emerged in large tropical
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Dengue is a reemerging disease in the neotropics and is
transmitted primarily by Ae. aegypti. The abundance in
Africa of closely related Aedes species within the
Stegomyia subgenus, the lack of closely related Stegomyia
species in the Americas, and the existence of sylvatic Ae.
aegypti (Ae. aegypti formosus) in Africa suggest an
African origin for this species (13–17). Movement of peo-
ple and their requisite water storage containers during the
17th to 19th centuries probably spread Ae. aegypti
throughout the tropics and subtropics. After World War II,
Ae. aegypti prevalence and distribution increased in Asia
and the Pacific Islands. Ae. aegypti was partially eradicat-
ed from tropical America in the 1940s and 1950s, but
peridomestic Ae. aegypti aegypti has now reinfested most
of the neotropics (12). 
The Asian tiger mosquito, Ae. albopictus, originally of
sylvatic origin as well, has spread widely in the world since
the 1970s, including to the United States, Latin America,
tropical Africa, the Pacific Islands, and Europe (7).
Although less anthropophagic than Ae. aegypti, it is a sec-
ondary vector of DENV and possibly of greater importance
in the early historical stages of urban dengue emergence. 
We hypothesized that all four endemic dengue viruses
evolved independently from sylvatic progenitors by adap-
tating to peridomestic mosquito vectors and human reser-
voir hosts (11). The rise of urban civilizations and the
associated peridomestication of Ae. aegypti and  Ae.
albopictus mosquitoes provided this opportunity for adap-
tation and resulted in the emergence of dengue in urban
areas of the tropics. This hypothesis predicts that endemic
DENV strains are more efficient at infecting urban mos-
quitoes such as Ae. aegypti and Ae. albopictus than are the
ancestral, sylvatic DENV strains. We tested this hypothe-
sis by using experimental infections of Ae. aegypti and Ae.
albopictus with sylvatic versus urban strains of DENV-2.
Our results support the hypothesis that adaptation to
peridomestic mosquito vectors mediated dengue emer-
gence from sylvatic progenitor viruses.
Methods
Mosquito Colonies 
Because geographic variation exists with regard to sus-
ceptibility to DENV in both colonized (18,19) and wild-
collected populations of Ae. aegypti and  Ae. albopictus
(20–22), mosquitoes from the United States, Brazil,
Bolivia, and Thailand were tested. These locations were
selected to represent a wide geographic range, including
regions with endemic dengue, and on the basis of availabil-
ity of specimens from collaborators. Because laboratory
colonization has been shown to affect susceptibility of mos-
quitoes to oral infection by flaviviruses (23,24), low filial
generation cohorts were used for susceptibility experi-
ments. Ae. aegypti and Ae. albopictus females were col-
lected during the fall of 2001 from Galveston, Texas, and
the first filial (F1) laboratory generation was used for
experiments. F1 generation Ae. aegypti females were also
hatched from eggs collected in Mae Sed, Tak, Thailand, in
2002. Second generation (F2) Ae. aegypti collected in Santa
Cruz, Bolivia, in 2002 were also used. From Brazil, F1 Ae.
albopictus from Pindamonhangaba City (an urban environ-
ment) and F1 and F2 Ae. albopictus from Pedrinhas City (a
rural environ) were used from a parental collection in 2001.
All mosquitoes were maintained in an insectary at 28°C,
with a relative humidity of 80% and a 12:12 light-dark cir-
cadian cycle. Adults were fed a hamster blood meal to
obtain eggs. Eggs were stored in plastic containers for up to
3 months. Larvae were reared on a diet of ground rabbit and
mouse chow. Pupae were transferred to screened cages, and
adults were fed 10% sucrose ad libitum. 
Virus Strains 
Low-passage isolates of DENV-2 were selected for this
study to represent similar geographic ranges for endemic
and sylvatic strains and based on the ability to obtain high-
titered stocks after passage in mosquito cell (C6/36) cul-
tures (Table 1); the strains included endemic strains New
Guinea C (prototype strain) and 1349 and sylvatic strains
PM 33974, A2022, and P81407. Virus stocks were prepared
on C6/36 cell cultures and quantified by infecting C6/36
cells in 96-well plates with serial dilutions, followed by cell
Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 10, No. 10, October 2004 1791
Dengue Emergence and Adaptation to Mosquitoesspotting in 12-well slides and immunofluorescence assays
(IFA) to determine 50% tissue culture infective doses
(TCID50) (see below). All work with DENVwas carried out
in a biosafety level 2 laboratory at the University of Texas
Medical Branch with recommended safety procedures (25). 
Indirect Fluorescent Antibody Test 
Infection of mosquitoes with DENV was assayed with
IFAin C6/36 cells, which is more sensitive than direct IFA
of mosquito tissues (data not shown). Mosquito bodies and
legs were triturated in Eagle’s minimal essential medium
(MEM) supplemented with 10% fetal bovine serum, 1%
nonessential amino acids, glutamine, and antimicrobial
agents (penicillin and streptomycin). Ten microliters of
each triturated suspension was added to 90 µL of MEM in
96-well microtiter plates. Plates were incubated for 7 days
at 28°C. After incubation, 10 µL suspensions of C6/36
cells were placed on multiwell slides, air dried, and fixed
in ice-cold 80% acetone. Slides were then incubated for 1
h at 37°C with a polyclonal anti-DENV-2 mouse ascitic
fluid diluted 1:80 in phosphate-buffered saline (PBS).
Slides were rinsed twice in PBS and overlaid with fluores-
cein isothiocyanate–labeled goat anti-mouse immunoglob-
ulin G (Sigma, St. Louis, MO) diluted 1:15 in PBS. Slides
were again incubated for 1 h at 37°C and washed twice in
PBS. Slides were examined at 200 to 1,000x with an
inverted fluorescent microscope. 
Vector Susceptibility 
Artificial blood meals consisting of 1% sucrose, 20%
fetal bovine serum, 5 mmol ATP, 33% PBS-washed sheep
blood cells, and 33% MEM were used for mosquito sus-
ceptibility determinations. Multiple cohorts of 30 to 50
mosquitoes were offered blood meals incubated at 37°C in
a water-jacketed membrane feeder (23). After 1 h of feed-
ing, engorged mosquitoes were sorted from unengorged
ones, and a sample of the blood meal was assayed to deter-
mine the virus titer. Fully engorged mosquitoes were incu-
bated for 14 days at 27°C with a 12:12 light-dark cycle.
Then, legs were detached from cold-anesthetized mosqui-
toes and assayed to determine the dissemination rate of the
virus from the midgut into the hemocoel (mosquito legs
include hemolymph, which is believed to mediate infec-
tion of the salivary glands). Bodies were assayed to deter-
mine the overall infection rate. Blood meal titers were
determined by IFAs on C6/36 cells (see above) of samples
collected immediately after mosquito feeding. 
Because mosquito infections caused by artificial blood
meals are inefficient compared to those using viremic
hosts, we used the highest virus titers available (6.5–10.0
log10 TCID50/mL) from cell culture passages for our exper-
iments. To interpret our data as conservatively as possible,
infection and dissemination rates for endemic strains were
only compared with rates from the same or higher blood
meal titers for sylvatic strains. Infection and dissemination
differences were tested for significance with chi-square
and Fisher exact tests with the SPSS (Chicago, IL) Base
11.5 statistical package. When no significant differences
were observed among endemic or sylvatic strains tested,
data were pooled for each group.
Results
Aedes aegypti Susceptibility
After ingestion of artificial blood meals containing
6.5–8.0 log10 TCID50/mL of endemic DENV-2, infection
and dissemination rates in Ae. aegypti mosquitoes from
Galveston, Texas, were 86.5%–100.0% and 90.6%–78.9%,
respectively (Table 2). Infection and dissemination rates
after exposure to sylvatic viruses were more variable but
lower, ranging from 11.4% to 69.4% and from 0% to
64.4% after ingestion of 8.0 to 10.0 log10 TCID50/mL of
DENV. Even after the (lowest) infection rate data for strain
1407 were removed from the pooled analysis because they
were significantly different than those for the other sylvat-
ic strains, both infection (p < 0.0001) and dissemination
(p = 0.01) rates were different between endemic and syl-
vatic strains (Table 2).
Ae. aegypti from Santa Cruz, Bolivia, had lower infec-
tion and dissemination rates than Galveston populations
after being exposed to endemic DENV strains. Infection
rates were 40.9%–48.1% and dissemination rates were
76.9%–77.8% with blood meal titers of 9.5 log10
TCID50/mL (Table 3). Infection and dissemination rates in
Bolivian mosquitoes exposed to sylvatic viruses were also
lower than those of Ae. aegypti from Galveston, and syl-
vanic strain infection rates in Bolivian mosquitoes were
lower (p = 0.015), ranging from 16.7% to 27.3%, than
those of endemic strains; dissemination rates were not sig-
nificantly different (p = 0.663). 
Ae. aegypti from Mae Sed, Tak, Thailand, were also
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2 strains used in this study, with the exception of endem-
ic DENV-2 strain 1349 from Burkina Faso (infection and
dissemination rates were 94.3% and 80%, respectively,
with this strain) (Table 4). Like the Galveston and
Bolivian populations, the Thai population exhibited con-
sistent differences in susceptibility to endemic versus syl-
vatic strains (33.0%–94.3% infection with the endemic
strains vs. 0%–13% for sylvatic strains; 84.8%–90.9%
dissemination rate for endemic strains vs. 0%–50% for
sylvatic strains). Infection rates for both endemic strains
were higher than for the pooled sylvatic rates (p < 0.001),
while dissemination rates were not significantly different
(p > 0.1). 
Ae. albopictus Susceptibility
Like Ae. aegypti, Ae. albopictus from Galveston, Texas,
exhibited greater susceptibility to endemic than sylvatic
DENV strains. After ingesting blood meals containing
6.5–8.0 log10 TCID50/mLof endemic strains, 92.3%–100%
of mosquitoes became infected, with high rates of dissem-
ination (Table 5). In contrast, only 11.1% of mosquitoes
became infected after ingesting 8.0 log10 TCID50/mLof the
sylvatic strain. The infection rates for endemic strains were
higher than for sylvatic strains (p < 0.0001), but the differ-
ence in dissemination was not significant (p = 1.000; only
one infected mosquito with a sylvatic strain was tested and
exhibited dissemination).
Ae. albopictus from two different locations in Brazil
were also tested. One location was urban,
Pindamonhangaba, while the other, Pedrinhas, was rural.
Again, a significant difference in susceptibility was
observed between endemic (strain New Guinea C) and syl-
vatic (strain 33974) infections with F1 mosquitoes of both
geographic locations (Pindamonhangaba, p < 0.001,
Pedrinhas, p < 0.001). However, no significant differences
were detected in dissemination rates for either F1 mosqui-
to population (p > 0.1). For the Pedrinhas mosquito popu-
lation, F2 mosquitoes were tested with additional endemic
and sylvatic strains. Again, the endemic strains infected at
a higher rate (p < 0.001) than sylvatic strains, even when
blood meal titers were lower (Table 6). Dissemination
rates were also markedly different (p = 0.004).
Geographic Variation in Susceptibility among
Mosquito Populations
Geographic variation for DENV susceptibility has been
reported previously for both Ae. aegypti and Ae. albopic-
tus (18,19). We found geographic variation among popula-
tions of both species. In general, Ae. aegypti from
Galveston, Texas, were more susceptible than those from
Bolivia (p < 0.001) but not those from Thailand (p > 0.1).
Ae. albopictus from Galveston were also more susceptible
to DENV-2 infection than those collected in Brazil
(p = 0.009). 
Overall Trends
In general, in the 701 peridomestic mosquitoes from
four localities used in this study, we found high suscepti-
bility to endemic DENV-2 isolates but much less suscepti-
bility to sylvatic strains. These differences were detected
despite the blood meal titers of sylvatic strains being equal
to or greater than those of endemic strains. Dissemination
rates within infected mosquitoes generally showed no sig-
nificant difference between endemic and sylvatic strains.
Our data also indicated that Ae. albopictus was more sus-
ceptible to endemic DENV-2 strains than Ae. aegypti
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aegypti and Ae. albopictus from one geographic location,
Galveston, we did not find a difference between mosquito
species when we compared infection with endemic strains
1349 (p > 0.1) or the New Guinea C strain (p > 0.1).
However, Galveston Ae. aegypti were more susceptible to
sylvatic strain 33974 than were Ae. albopictus from
Galveston (p = 0.026).
Discussion
Historical Emergence of Dengue and 
Adaptation to Peridomestic Vectors
Our findings support the hypothesis that endemic
DENV-2 strains are more efficient than sylvatic strains at
infecting the peridomestic DENV vectors Ae. aegypti and
Ae. albopictus. The overall trend that endemic DENV-2
strains were consistently more efficient at infecting perido-
mestic  Aedes mosquitoes than were sylvatic DENV-2
strains (p = 0.000) supports our central hypothesis. Our
data and previous phylogenetic studies (11) suggest that
the emergence of endemic DENV from sylvatic progenitor
strains occurred in conjunction with the peridomestication
of Aedes mosquitoes and virus adaptation to these anthro-
pophilic vectors. Although we tested only DENV-2 strains,
emergence of DENV serotypes 1, 3, and 4 may also have
been mediated by vector switching (from infecting sylvat-
ic Aedes mosquitoes to Ae. aegypti and Ae. albopictus).
Very few sylvatic DENV-1 and 4 strains are available (and
none of DENV-3), which makes evaluating this hypothesis
difficult. 
The four independent evolutionary DENV emergence
events (DENV-1–4) suggest that adaptation of DENV to
new vectors and hosts occurred repeatedly from 300 to
1,500 years ago in Asia or Oceania (11,26). Since Ae.
aegypti is not thought to have inhabited these regions at
that time, Ae. albopictus was probably the original human
vector (12).The widespread importance of Ae. aegypti as a
vector may have begun in the 1700s, as commercial and
slave trade transported it from its African origin. DENV-2
was probably introduced into Africa from Asia-Oceania
approximately 1,000 years ago (11). The hypothesis that
Ae. albopictus was the original peridomestic vector was
supported by our study; Ae. albopictus was more suscepti-
ble to endemic DENV-2 strains than Ae. aegypti. The
greater overall susceptibility (regardless of geographic ori-
gin) of Ae. albopictus compared to Ae. aegypti (94% and
69%, respectively) suggests a higher degree of adaptation,
representing longer historical contact with Ae. albopictus.
Other studies with sympatric populations from Brazil
show Ae. aegypti to be more susceptible than Ae. albopic-
tus to endemic DENV-2 (19,20). 
Risk for Dengue in the United States
When the vectorial capacity of a mosquito for an
arbovirus is considered, many factors come into play,
including mosquito survivorship, density, proportion of
infected mosquitoes that are feeding, extrinsic incubation
period, vector susceptibility, and density of susceptible
hosts (27). We used vector susceptibility in this study as a
measure not only of epidemiologic importance but also of
the extent of adaptation of a virus to its vector. However,
the full competence of a vector is established not only by its
ability to become infected but also by its ability to transmit
a pathogen. This feature is what gives vector competence
its epidemiologic importance. In our study, transmission
potential was estimated from dissemination rates because
previous studies have suggested that mosquitoes are capa-
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seminate from the midgut into the hemocoel (i.e., there is
no evidence of a salivary gland infection barrier) (18).
Mosquitoes that have a disseminated infection were there-
fore assumed to be capable of transmission.
Current methods of dengue control rely primarily on
mosquito control and are aimed at reducing the popula-
tions of urban vectors, especially Ae. aegypti. This mos-
quito was eradicated from much of the New World during
the middle of the 20th century. After the termination of the
Ae. aegypti eradication program, Ae. aegypti populations
reinfested many of the New World countries from which
they had been eliminated, probably from those that did not
achieve eradication. Being well adapted to urban environ-
ments and competent for transmission, DENV has become
the most important mosquitoborne virus in the neotropics.
Air travel and migration have increased the movement of
virus strains around the world. Dengue virus has frequent-
ly been imported into the United States, where local trans-
mission has been reported (28). Much of the southern
United States is at risk for dengue transmission because of
the presence of endemic Ae. aegypti and Ae. albopictus.
Our study suggests that local populations of both species
from Galveston are highly susceptible and potentially able
to transmit DENV-2 from Africa, Asia, and Oceania. 
Implications for Dengue Control
Promising candidate dengue vaccines are raising hopes
of effectively preventing human disease (29). Because
humans are the only reservoir host for the endemic cycle,
an effective vaccine could ultimately eradicate endemic
strains. This scenario underscores the need for greater
understanding of the historical emergence of human
dengue from sylvatic origins to predict the facility with
which the sylvatic strains could reemerge to initiate urban
transmission. The four independent emergence events
(DENV-1–4) suggest that the host-range changes that
accompanied emergence can be readily accomplished by
DENV; however, this hypothesis needs to be tested exper-
imentally. One question to be answered is how many muta-
tions are responsible for the efficient infection phenotype
for Ae. aegypti and Ae. albopictus exhibited by the endem-
ic DENV-2 strains. Identifying genetic determinants of
DENV adaptation to these peridomestic vectors will ulti-
mately provide an indication of the ability of these
arboviruses to reemerge. 
The viral molecular determinants that confer DENV
with the ability to infect and be transmitted by their mos-
quito vectors are not known. Phylogenetic studies suggest
that the DENV E protein may be important in the adapta-
tion to urban vectors (11). In particular, domain III of the
E protein contains several hypothetical amino acid
replacements associated with emergence of urban strains.
This clustering of changes in domain III is observed
repeatedly during the emergence of DENV-1, DENV-2,
and DENV-4, when phylogenetic methods are used. The
envelope glycoproteins of other mosquitoborne viruses,
including Sindbis (30), Venezuelan equine encephalitis
(31–33), and La Crosse viruses (34), have been shown to
mediate vector infection. Another genomic region poten-
tially important in mediating vector transmission may be
the 5′ noncoding region. Deletions in this region of DENV-
4 constrain its ability to infect Ae. aegypti and Ae. albopic-
tus mosquitoes (35). 
Our study examined the extent of endemic DENV
adaptation to peridomestic vectors. If this adaptation is
species-specific, then sylvatic vectors may be more sus-
ceptible to infection by sylvatic than endemic DENV
strains. We are currently evaluating this hypothesis with
sylvatic West African vectors.
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